Results of Operations and Financial Condition. On July 22, 2026, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the second quarter ended June 30, 2026 and increasing the Company’s full-year 2026 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this Form 8-K and the…

Annual board election with no specific departures or appointments mentioned.

Regulation FD Disclosure. As previously announced, Molina Healthcare, Inc. (the “Company”) will host its Investor Day Conference on May 8, 2026, beginning at 9:30 a.m. Eastern Time. At the event, the Company will provide various updates regarding its business, including on its long-term financial targets and strategic and operational plans. A copy of the Investor Day presentation materials is attached hereto as Exhibit 99.1 and incorporated herein by reference. A live webcast of the Company’s…

Results of Operations and Financial Condition. On April 22, 2026, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the first quarter ended March 31, 2026 and reaffirming the Company’s full-year 2026 premium revenue and adjusted earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The infor…

Regulation FD Disclosure. 2026 Outlook Affirmation Members of the senior management team of Molina Healthcare, Inc. (“Molina” or the “Company”) will be meeting with investors and analysts over the next several days, and on Tuesday, March 3, 2026, will also be participating in TD Cowen’s 46 th Annual Health Care Conference. Consistent with the Company’s guidance previously provided on February 6, 2026, the senior management team plans to reaffirm the Company’s 2026 full year GAAP diluted earni…

Material Impairments On February 5, 2026, the Company concluded that it will record in the first quarter of 2026 an estimated non-cash, pre-tax impairment charge of approximately $93 million, attributable to certain of its intangible assets. This impairment charge results from the Company’s decision to exit the Medicare Advantage Prescription Drug product for 2027 as that product does not align with the Company’s strategic shift to focus exclusively on dual eligible members in Medicare. This…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Entry into a Material Definitive Agreement. On February 4, 2026, Molina Healthcare, Inc. (the “Company”) entered into a First Amendment to its Credit Agreement (the “Amended Credit Agreement”) among the Company, as the Borrower, the Lenders (as defined therein) party thereto, and Truist Bank, as Administrative Agent. The Amended Credit Agreement amends the Company’s prior Credit Agreement dated as of November 20, 2025 (the “Prior Credit Agreement”). The terms of the Amended Credit Agreement a…

Results of Operations and Financial Condition. On February 5, 2026, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2025 and the Company’s full-year 2026 revenue and earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this…

Entry into a Material Definitive Agreement. 6.500% Senior Notes due 2031 On November 20, 2025 (the “Settlement Date”), Molina Healthcare, Inc., a Delaware corporation (the “Company”), completed the private offering of $850.0 million aggregate principal amount of the Company’s 6.500% Senior Notes due 2031 (the “Notes”) pursuant to an indenture, dated as of the Settlement Date, by and between the Company and U.S. Bank Trust Company, National Association, as trustee, attached as Exhibit 4.1 to t…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Regulation FD Disclosure. On November 17, 2025, Molina Healthcare, Inc., a Delaware corporation (the “Company”), announced that it had priced $850 million aggregate principal amount of the Company’s 6.500% senior notes due 2031 (the “Notes”), in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States in relian…

of this Current Report on Form 8-K (this “Report”) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed by Molina Healthcare, Inc. (the “Company”) under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be e…

Results of Operations and Financial Condition. On October 22, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the third quarter ended September 30, 2025 and updating the Company’s full-year 2025 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this Form 8-K an…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Entry into a Material Definitive Agreement to Partially Fund a Stock Repurchase Program. On August 12, 2025, Molina Healthcare, Inc. (the “Company”) entered into a Fourth Amendment to its Credit Agreement (the “Amended Credit Agreement”) among the Company, as the Borrower, the Lenders (as defined therein), and Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender. The Amended Credit Agreement amends and restates the Company’s prior Credit Agreement dated as of June 8, 2020 (…

Results of Operations and Financial Condition. On July 23, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the second quarter ended June 30, 2025 and updating the Company’s full-year 2025 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this Form 8-K and the e…

Results of Operations and Financial Condition. On July 7, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited financial results for the second quarter of 2025 and updating its full year 2025 adjusted earnings per share guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in…

The provided text is only the standard Item 5.02 header and a truncated date, lacking any specific details about a person, role, or action to classify the event.

Results of Operations and Financial Condition. On April 23, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the first quarter ended March 31, 2025 and reaffirming the Company’s full-year 2025 revenue and earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this Fo…

Entry into a Material Definitive Agreement. On February 19, 2025, Molina Healthcare, Inc. (the “Company”) entered into a Third Amendment to its Credit Agreement (the “Amended Credit Agreement”) among the Company, as the Borrower, the Lenders (as defined therein), and Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender. The Amended Credit Agreement amends and restates the Company’s prior Credit Agreement dated as of June 8, 2020 (as amended prior to February 19, 2025, the “…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Results of Operations and Financial Condition. On February 5, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2024 and the Company’s full-year 2025 revenue and earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this…

Regulation FD Disclosure. On February 3, 2025, Molina Healthcare, Inc. (the “Company”) announced that its acquisition of ConnectiCare Holding Company, Inc. closed effective as of February 1, 2025. The full text of the Company’s press release issued in connection with the announcement is included as Exhibit 99.1 to this report. Note: The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in